ASTM Financial Facts
Selling, general and administrative: 1.7MInterest expense: -3K
See Full Income Statement
Total liabilities and shareholders' equity (deficit): 14.07M
Receivables: 9K
See Full Balance Sheet
Aastrom Biosciences, Inc. (ASTM) Earnings
|
Expand Research on ASTM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +27.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/14  |
Q314 | -$0.52 | -$0.66 | +$0.14 | $9.66M | $6.73M | N/A |  | | Details | |
| 8/14/14 | Q214 | -$0.94 | N/A | N/A | $4.43M | $3K | N/A | | | Details | |
| 5/15/14 | Q114 | -$1.26 | -$0.92 | -$0.34 | N/A | N/A | N/A | | | Details | |
| 3/13/14 | Q413 | -$0.97 | -$1.34 | +$0.37 | $8K | $19K | N/A | | | Details | |
| 11/12/13 | Q313 | -$0.06 | -$2.02 | +$1.96 | N/A | N/A | N/A | | | Details | |
| 5/8/13 | Q113 | -$0.15 | -$0.19 | +$0.04 | N/A | N/A | N/A | | | Details | |
| 3/18/13 |
Q412 | -$0.18 | -$0.23 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 11/30/-1 | Q411 | -$0.07 | N/A | N/A | N/A | $253K | N/A | | | Details |
